Search results

Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

Research to understand how contaminants move through the soil and affect ecosystems and humans as well estimating emissions.

A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.

State- of-the-art microdosimeters used in research

Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.

Research explores how structure contributes to function in food

The Centre for Accelerator Science provides complementary capabilities to Synchrotron-based and the neutron-based research with the operation of four accelerators, associated beamlines, clean laboratories and in-house expertise in ion beam analysis (IBA) and accelerator mass spectrometry (AMS).

An Australian-led international research team, including a core group of ANSTO scientists, has found that doping a promising material provides a simple, effective method capable of extracting uranium from seawater.

Australia’s best known carnivorous dinosaur Australovenator is under the microscope at ANSTO

The ANSTO Senior Leaders review and agree on issues and actions with organisation-wide significance.

ANSTO-nandin hackathon teams have combined skills using science and business innovation in three successive events.

Neutron imaging or tomography creates a whole series of three-dimensional images of an object that can be reconstructed.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.  

A collaboration of scientists from RMIT, ANSTO and the CSIRO has published pioneering research that brings new insights into intrinsically disordered proteins and protein regions (IDPs)/ (IDRs) and how they behave under various physiological processes.

International interest is building in Australia’s new multi-million-dollar radioactive waste processing facility at the Sydney campus of the Australian Nuclear Science and Technology Organisation (ANSTO).